🇺🇸 FDA
Patent

US 9370559

Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

granted A61KA61K2239/49A61K2239/50

Quick answer

US patent 9370559 (Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1) held by The United States of America, as represented by the Secretary, Department of Heath Services expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Heath Services
Grant date
Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2239/49, A61K2239/50, A61K2239/57, A61K40/11